Nicholas Investment Partners’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,381,983
| Closed | -$13.4M | – | 215 |
|
|
2021
Q2 | $13.4M | Buy |
1,381,983
+35,230
| +3% | +$342K | 0.84% | 44 |
|
|
2021
Q1 | $14.5M | Buy |
1,346,753
+579,369
| +75% | +$6.22M | 1.01% | 39 |
|
|
2020
Q4 | $11.3M | Buy |
767,384
+193,755
| +34% | +$2.85M | 0.87% | 40 |
|
|
2020
Q3 | $8.15M | Buy |
+573,629
| New | +$8.15M | 0.88% | 41 |
|
|
2016
Q1 | – | Sell |
-27,095
| Closed | -$342K | – | 346 |
|
|
2015
Q4 | $342K | Buy |
27,095
+315
| +1% | +$3.98K | 0.02% | 280 |
|
|
2015
Q3 | $349K | Buy |
26,780
+19,476
| +267% | +$254K | 0.03% | 292 |
|
|
2015
Q2 | $159K | Buy |
+7,304
| New | +$159K | 0.01% | 304 |
|